Belpointe Asset Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Belpointe Asset Management's HALO Position: Q3 2026 in Review
Belpointe Asset Management reduced its Halozyme (HALO) stake by 13% in Q3 2026, selling an estimated $200K and leaving 13,616 shares worth $1.5M. The position accounts for 0.04% of the portfolio, ranked #399.
Belpointe Asset Management first reported a position in HALO in Q4 2022 and has held it in 9 quarters since. 636 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- Belpointe Asset Management held 13,616 shares of Halozyme worth $1.5M as of Q3 2026.
- Belpointe Asset Management sold 2,066 Halozyme shares in Q3 2026, an estimated $200K.
- Halozyme made up 0.04% of Belpointe Asset Management's portfolio in Q3 2026, its #399 holding.
- Belpointe Asset Management first reported a position in Halozyme in Q4 2022 and has held it in 9 quarters since.
- 636 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on Belpointe Asset Management's 13F filing for Q3 2026, filed 9 Nov 2026.